Showing 1 - 4 results of 4 for search 'Michael Wölfl-Duchek', query time: 0.03s
Refine Results
-
1
Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2 by Martin Bauer, Anselm Jorda, Valentin al-Jalali, Michael Wölfl-Duchek, Felix Bergmann, Alina Nussbaumer-Pröll, Ariane Steindl, Romana Gugenberger, Sarah Bischof, Doris Wimmer, Marco Idzko, Markus Zeitlinger
Published 2024-02-01
Article -
2
Early Bacterial Coinfections in Patients Admitted to the ICU With COVID-19 or Influenza: A Retrospective Cohort Study by Felix Bergmann, MD, Cornelia Gabler, MSc, Alina Nussbaumer-Pröll, PhD, Michael Wölfl-Duchek, MD, Amelie Blaschke, MD, Christine Radtke, MD, Markus Zeitlinger, MD, Anselm Jorda, MD
Published 2023-04-01
Article -
3
[11C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patients by Myriam El Biali, Louise Breuil, Matthias Jackwerth, Severin Mairinger, Maria Weber, Michael Wölfl-Duchek, Karsten Bamminger, Ivo Rausch, Lukas Nics, Marcus Hacker, Sebastian Rodrigo, Viviane Bouilleret, Markus Zeitlinger, Ekaterina Pataraia, Nicolas Tournier, Martin Bauer, Oliver Langer
Published 2024-10-01
Article -
4
St. John's wort extract with a high hyperforin content does not induce P‐glycoprotein activity at the human blood–brain barrier by Myriam El Biali, Michael Wölfl‐Duchek, Matthias Jackwerth, Severin Mairinger, Maria Weber, Karsten Bamminger, Stefan Poschner, Ivo Rausch, Natalie Schindler, Irene Hernández Lozano, Walter Jäger, Lukas Nics, Nicolas Tournier, Marcus Hacker, Markus Zeitlinger, Martin Bauer, Oliver Langer
Published 2024-05-01
Article